Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Bettina J. Kraus, Matthew R. Weir, George L. Bakris, Michaela Mattheus, David Z.I. Cherney, Naveed Sattar, Hiddo J.L. Heerspink, Ivana Ritter, Maximilian von Eynatten, Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, Audrey Koitka‐Weber
Topics & Concepts
EmpagliflozinMedicineRenal functionInternal medicineDiureticHazard ratioPlaceboKidney diseaseOdds ratioUrologyConfidence intervalType 2 diabetesDiabetes mellitusEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies